These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 3191476

  • 1. Purification and characterization of phosphohexose isomerase from human gastrointestinal carcinoma and its potential relationship to neuroleukin.
    Baumann M, Brand K.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7018-21. PubMed ID: 3191476
    [Abstract] [Full Text] [Related]

  • 2. The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase.
    Chaput M, Claes V, Portetelle D, Cludts I, Cravador A, Burny A, Gras H, Tartar A.
    Nature; 1988 Mar 31; 332(6163):454-5. PubMed ID: 3352744
    [Abstract] [Full Text] [Related]

  • 3. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
    Watanabe H, Takehana K, Date M, Shinozaki T, Raz A.
    Cancer Res; 1996 Jul 01; 56(13):2960-3. PubMed ID: 8674049
    [Abstract] [Full Text] [Related]

  • 4. Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3' sequences.
    Faik P, Walker JI, Redmill AA, Morgan MJ.
    Nature; 1988 Mar 31; 332(6163):455-7. PubMed ID: 3352745
    [Abstract] [Full Text] [Related]

  • 5. Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells.
    Niinaka Y, Paku S, Haga A, Watanabe H, Raz A.
    Cancer Res; 1998 Jun 15; 58(12):2667-74. PubMed ID: 9635595
    [Abstract] [Full Text] [Related]

  • 6. Purification and partial characterization of human intracellular B cell growth factor.
    Sahasrabuddhe CG, Martin B, Maizel AL.
    Lymphokine Res; 1986 Jun 15; 5(2):127-40. PubMed ID: 3486330
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Purification and partial characterization of a thrombin-like/gyroxin enzyme from bushmaster (Lachesis muta rhombeata) venom.
    Aguiar AS, Alves CR, Melgarejo A, Giovanni-de-Simone S.
    Toxicon; 1996 May 15; 34(5):555-65. PubMed ID: 8783450
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A factor from plasma-derived human serum that inhibits the growth of the mammary cell line MCF-7: characterization and purification.
    Dell'Aquila ML, Pigott DA, Bonaquist DL, Gaffney EV.
    J Natl Cancer Inst; 1984 Feb 15; 72(2):291-8. PubMed ID: 6582317
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Partial purification of murine B cell stimulatory factor (BSF)-1.
    Ohara J, Lahet S, Inman J, Paul WE.
    J Immunol; 1985 Oct 15; 135(4):2518-23. PubMed ID: 3875657
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Purification of exo-1,4-beta-xylosidase from Aspergillus niger 15].
    Tavobilov IM, Rodionova NA, Akparov VKh, Bezborodov AM.
    Prikl Biokhim Mikrobiol; 1982 Oct 15; 18(5):671-80. PubMed ID: 6815635
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer.
    Baumann M, Kappl A, Lang T, Brand K, Siegfried W, Paterok E.
    Cancer Invest; 1990 Oct 15; 8(3-4):351-6. PubMed ID: 2207761
    [Abstract] [Full Text] [Related]

  • 19. Human leukocyte glucose-phosphate-isomerase purification by affinity elution and immunological study.
    Bertrand O, Kahn A, Cottreau D, Boivin P.
    Biochimie; 1976 Oct 15; 58(3):261-7. PubMed ID: 819039
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.